New MS medication siponimod has received approval in the United States for use in people with relapsing forms of MS which includes active secondary progressive MS.
A new study has shown that early intensive treatment for MS gives better outcomes than starting on a moderately effective therapy and escalating to stronger medication.
Four of the 2019 awarded MS Research Australia grants focus on innovative ways to use MRI to better understand MS, rather than simply as a clinical tool.
MS Research Australia is pleased to be supporting several high calibre new research projects which focus on the link between diet and MS.
Despite having a similar core temperature to those without MS while resting and exercising, people with MS show a significantly reduced sweat response.
This May we would like to invite you to help Kiss Goodbye to MS by signing up for our new fundraising activity – The May 50K!
MS predominately affects young women at an age when many are starting or growing their families, making treatment
Trevor Bolland tells his story of father-daughter fundraising for MS research, from the moment his beloved daughter Monique was diagnosed with MS to today.
About this episode – Gut bacteria and MS In this episode we speak to Dr Wolfgang Marx at
